As the gold standard for pharmacokinetic and pharmacodynamics (PK/PD) software, Phoenix 8.0 continues to innovate and deliver new features to WinNonlin, NLME, and its workbench to reduce errors, save time, and support the regulatory review process. Phoenix 8.0 is a significant update to the most advanced PK/PD software used worldwide by over 6,000 researchers, nearly 2,000 institutions, and multiple regulatory agencies including 11 divisions of the FDA to analyze PK/PD data.
- Enhanced NCA Engine with Phoenix WinNonlin 8.0: Phoenix WinNonlin 8.0 provides automated calculation of over a dozen new parameters for plasma and urine which will save time by eliminating manual work and reduce errors with non-compartmental analysis. Users can also define their own parameters such as compute concentrations at any time point and arithmetic combinations of any NCA parameter. Furthermore, users can set strict criteria for the calculation of the terminal slope in NCA to ensure compliance with organizational policies and procedures.
- All New WinNonlin 8.0 Validation Suite Available at Launch: The new validation suite is integrated into Phoenix 8.0 so there is no need to wait to validate or to install a separate application. The average run time for the new validation suite takes less than 30 minutes, significantly less than other validation options which can take days. Validation results are saved and immediately available in Phoenix 8.0 for easy reference.
- Faster Model Runs with Phoenix NLME 8.0: Phoenix NLME 8.0 offers parallelization to run on powerful remote compute platforms, reducing run times from days to minutes. Phoenix NLME 8.0 also includes the distributed delay function to model delayed outcomes in therapeutic areas such as oncology, diabetes and arthritis.
- New Features in the Phoenix Workbench: For quality control, users can now lock Phoenix workflows to prevent any changes and load and save object settings with one click.
In this webinar, Dr. Nathan Teuscher will demonstrate how to get the most out of Phoenix 8.0’s new features, including how to automatically calculate new NCA parameters, set up parallelization of Phoenix NLME runs, and leverage the new validation suite to get up and running in no time.
About Our Speaker
Nathan Teuscher is the Vice President of Pharmacometric Solutions at Certara. He is a leader in the pharmaceutical industry as a scientist, consultant, and teacher. Nathan has been teaching and training for over 15 years in the pharmaceutical industry, providing lectures in general pharmacokinetics to non-scientists, and specialized training in population pharmacokinetics and drug development to industry experts.